Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Drukarch

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
European Journal of Pharmacology|December 29, 1995
Intermittent morphine treatment causes long-term desensitization of functional dopamine D2 receptors in rat striatumP Nestby, G H Tjon, D T Visser, et al.
Neuropathology and Applied Neurobiology|April 8, 2006
Changed distribution pattern of the constitutive rather than the inducible HSP70 chaperone in neuromelanin-containing neurones of the Parkinsonian midbrainG Andringa, J G J M Bol, X Wang, et al.
Psychopharmacology|April 1, 1995
Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeysR J Vermeulen, B Drukarch, M C Sahadat, et al.
Neuroreport|July 29, 1996
Presence of glutathione immunoreactivity in cultured neurones and astrocytesC H Langeveld, E Schepens, C A Jongenelen, et al.
Free Radical Biology & Medicine|October 6, 2000
L-Dopa stimulates expression of the antioxidant enzyme NAD(P)H:quinone oxidoreductase (NQO) in cultured astroglial cellsF L van Muiswinkel, F M Riemers, G J Peters, et al.
European Journal of Pharmacology|October 9, 1990
Lack of a dopamine autoreceptor selective profile of B-HT 920 in functional in vitro model systems of D2 receptors in rat striatumB Drukarch, E Schepens, M J Dolleman-Van der Weel, et al.
European Journal of Pharmacology|August 12, 1999
Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacyJ C Stoof, A Winogrodzka, F L van Muiswinkel, et al.
Synapse (New York, N.Y.)|June 1, 1994
No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeysR J Vermeulen, B Drukarch, N P Verhoeff, et al.
Neuropathology and Applied Neurobiology|April 15, 2015
The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathyM de Jager, M V Boot, J G J M Bol, et al.
Neurobiology of Aging|August 18, 2004
Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigraF L van Muiswinkel, R A I de Vos, J G J M Bol, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Pharmacology|December 29, 1995
Intermittent morphine treatment causes long-term desensitization of functional dopamine D2 receptors in rat striatumP Nestby, G H Tjon, D T Visser, et al.
Neuropathology and Applied Neurobiology|April 8, 2006
Changed distribution pattern of the constitutive rather than the inducible HSP70 chaperone in neuromelanin-containing neurones of the Parkinsonian midbrainG Andringa, J G J M Bol, X Wang, et al.
Psychopharmacology|April 1, 1995
Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeysR J Vermeulen, B Drukarch, M C Sahadat, et al.
Neuroreport|July 29, 1996
Presence of glutathione immunoreactivity in cultured neurones and astrocytesC H Langeveld, E Schepens, C A Jongenelen, et al.
Free Radical Biology & Medicine|October 6, 2000
L-Dopa stimulates expression of the antioxidant enzyme NAD(P)H:quinone oxidoreductase (NQO) in cultured astroglial cellsF L van Muiswinkel, F M Riemers, G J Peters, et al.
European Journal of Pharmacology|October 9, 1990
Lack of a dopamine autoreceptor selective profile of B-HT 920 in functional in vitro model systems of D2 receptors in rat striatumB Drukarch, E Schepens, M J Dolleman-Van der Weel, et al.
European Journal of Pharmacology|August 12, 1999
Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacyJ C Stoof, A Winogrodzka, F L van Muiswinkel, et al.
Synapse (New York, N.Y.)|June 1, 1994
No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeysR J Vermeulen, B Drukarch, N P Verhoeff, et al.
Neuropathology and Applied Neurobiology|April 15, 2015
The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathyM de Jager, M V Boot, J G J M Bol, et al.
Neurobiology of Aging|August 18, 2004
Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigraF L van Muiswinkel, R A I de Vos, J G J M Bol, et al.
Pageof 6